NCT05953116

Brief Summary

The study aims to determine the effect of protein nutrition and exercise on the body composition and functional capacity of Filipino older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 19, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 4, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

March 11, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

July 12, 2023

Last Update Submit

March 10, 2025

Conditions

Keywords

SarcopeniaBody CompositionProteinExerciseFunctional Status

Outcome Measures

Primary Outcomes (5)

  • Change in muscle mass, as measured by dual-energy x-ray absorptiometry (DXA)

    Measurement of appendicular skeletal muscle mass index (ASMI) by dividing total muscle mass (kg) of appendages with height in meters squared

    Baseline, Midline (6 weeks), Endline (12 weeks)

  • Change in muscle strength, as measured by grip strength and leg strength (Jamar, MicroFET)

    Handgrip strength is measured using a hydraulic hand dynamometer through maximum exertion of grip force (in kilograms). Leg strength is measured using a hand-held dynamometer. Participant will use strongest leg force to push against the resistance brought upon by the researcher while holding the measuring device.

    Baseline, Midline (6 weeks), Endline (12 weeks)

  • Change in physical performance, as measured by timed up-and-go test

    Faster time duration to complete the test indicate lesser risk for falls

    Baseline, Midline (6 weeks), Endline (12 weeks)

  • Change in physical performance, as measured by short physical performance battery

    Score ranges from 0 to 12 with a higher score indicating better functionality

    Baseline, Midline (6 weeks), Endline (12 weeks)

  • Change in physical performance, as measured by 10-meter walk test

    Faster walking speed (in meters per second) indicate better functionality

    Baseline, Midline (6 weeks), Endline (12 weeks)

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

A protein product (combination of whey protein and plant-derived protein) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Dietary Supplement: Nutrition supplementationOther: Exercise

Placebo Group

PLACEBO COMPARATOR

An isocaloric product (made with maltodextrin) in powdered form with flavoring. Product will be added to 180-200 mL of warm water prior to consumption.

Dietary Supplement: Nutrition supplementationOther: Exercise

Interventions

Nutrition supplementationDIETARY_SUPPLEMENT

Blinded researchers will provide the randomly assigned supplement product to the trial participants for a period of 90 days. Used packaging will be collected at the end of every week from each trial participant to monitor compliance.

Also known as: Protein drink
Intervention GroupPlacebo Group

Trained researchers will facilitate resistance-based exercises two to three times a week in an enclosed venue (gym). Trial participants will be assessed at baseline for one repetition maximum (1RM) which will serve as a basis for load progression. A target of 3 sets and 6-15 repetitions with at least 30 seconds rest in between sets will be performed by the trial participants under supervision of a trained researcher.

Also known as: Resistance and group exercise
Intervention GroupPlacebo Group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pre-sarcopenia/pre-frail
  • Aged 60 years old and above, male or female
  • Free-living in the community, ambulatory
  • Able to respond to food recall/interview as self-declared
  • Normal cardiac function as measured by resting ECG

You may not qualify if:

  • Bed ridden, unable to perform exercise independently
  • Presence of serious medical condition (i.e. cancer, existing fracture)
  • Presence of unmanaged hypertension and/or type 2 diabetes or upon assessment of physician
  • Renal Problem
  • Under controlled or medically-supervised diet not flexible to include the intervention agent
  • Allergic to any ingredients in the nutrition supplementation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Science and Technology-Food and Nutrition Research Institute

City of Taguig, National Capital Region, 1631, Philippines

Location

MeSH Terms

Conditions

SarcopeniaMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Robby Carlo A Tan, Msc

    Department of Science and Technology-Food and Nutrition Research Institute (DOST-FNRI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The trial participants and researchers will be blinded during the conduct of the 12-week intervention. An independent third party will handle randomization and allocation of participants to either intervention group (DOST-FNRI protein drink + physical activity) or placebo group (placebo product + physical activity), while trying to ensure a balanced sex distribution between the groups. The intervention group will receive a protein-containing product which shall meet the target of 30g of protein per day of supplementation. Meanwhile, the placebo group will receive an isocaloric product (similar caloric value but with minimal to no protein content). Both products will have similar packaging, appearance, taste, and flavoring. A unique serial number only known by the independent third party will be used to differentiate between the two products. Unblinding of trial participants will be done after data analysis of a locked dataset.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Science Research Specialist

Study Record Dates

First Submitted

July 12, 2023

First Posted

July 19, 2023

Study Start

September 4, 2023

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

March 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations